RE:The Ball is in THTX's CourtI absolutely share that opinion the remarkable achievements to get NASH phase 3 soon to end line as per agencies approval of the protocol, starting the oncology platform in timely manner and increasing sales in the middle of pandemic when others have failed can't go unrecognized by the market so now they need to market it hard and effectively.
Attending as many conferences, using social media platforms, reaching out to fund managers etc etc is what this company needs to do so all these great achievements get noticed by the whole market.
longterm56 wrote: The waiting for other people and/or institutions is now over ... and what happens from here on is solely in the Thera's court. We are no longer waiting on the NASH experts, the FDA, test results from NIH, papers being published .... it is now all on Thera.
Some say we are waiting on the analysts to get it right, but they have spoken. They might be lazy or ignorant of the details of what Thera has, but that doesn't matter ... the reason their reports are not supportive is because THEY ARE UNCONVINCED ... and the responsibility for changing that is solely on Thera.
So ... Paul ... no pressure ... lol.
-LT